Comparison of subcutaneous and intravenous administration of pancreatic stimulants.
D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology; D004285:Dogs; D005747:Gastric Fistula; D005753:Gastric Mucosa; D005755:Gastrins / Q000494:pharmacology*; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007413:Intestinal Mucosa; D010179:Pancreas / Q000187:drug effects* / Q000502:physiology*; D010185:Pancreatic Fistula; D012633:Secretin / Q000494:pharmacology*; D014020:Tissue Extracts / Q000494:pharmacology
D005755:Gastrins; D005768:Gastrointestinal Hormones; D014020:Tissue Extracts; D012633:Secretin; D002766:Cholecystokinin